Investigadores de Primera Línea en Cánceres de Sangre Raros Estudiarán una Nueva Estrategia Terapéutica Dirigida a las Células Madre Leucémicas BRONX, N.Y., 28 de noviembre de 2023 /PRNewswire-HISPANIC PR WIRE/ — La leucemia mieloide aguda (LMA) y los síndromes mielodisplásicos (SMD)…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.